A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung CancerShun Lu, Chengping Hu, Li Lü et al.|Journal of Thoracic Oncology|2015Cited by 44
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Shun Lü, Ziming Li et al.|Clinical Cancer Research|2017Cited by 20
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancerShun Lü, Yibin Wang, Yongfeng Yu et al.|Translational Lung Cancer Research|2025Cited by 2